GLOW (GHK-Cu + TB-500 + BPC-157)

Regenerative Stack

Also known as: GLOW Stack, Beauty Stack, Regenerative Trio

The GLOW stack is a pre-mixed regenerative beauty and healing blend combining three powerful repair peptides in a single vial. GHK-Cu (Copper Peptide) drives collagen remodeling, elastin production, and deep skin renewal at the gene expression level. TB-500 (Thymosin Beta-4) promotes systemic tissue repair through cell migration, angiogenesis, and anti-inflammatory signaling. BPC-157 (Body Protection Compound) accelerates wound healing, protects gut mucosa, and enhances blood vessel formation. Together, they create a synergistic repair cascade targeting skin aging, tissue damage, and chronic inflammation from multiple pathways simultaneously.

Dose in studies
2.3 mg. May vary by formulation – dose based on total vial content and supplier guidelines.
Frequency
Daily subcutaneous injection (per supplier protocol)
Cycle length
8-12 weeks on, 4 weeks off
Half-life
Blend half-life varies by component (1-4 hours). Designed for once-daily injection as a pre-mixed formulation.
Research level
2/5 – Limited research

GLOW (GHK-Cu + TB-500 + BPC-157) dosage chart

Frequently asked questions about GLOW (GHK-Cu + TB-500 + BPC-157)

What is GLOW (GHK-Cu + TB-500 + BPC-157)?

The GLOW stack is a pre-mixed regenerative beauty and healing blend combining three powerful repair peptides in a single vial. GHK-Cu (Copper Peptide) drives collagen remodeling, elastin production, and deep skin renewal at the gene expression level. TB-500 (Thymosin Beta-4) promotes systemic tissue repair through cell migration, angiogenesis, and anti-inflammatory signaling. BPC-157 (Body Protection Compound) accelerates wound healing, protects gut mucosa, and enhances blood vessel formation. Together, they create a synergistic repair cascade targeting skin aging, tissue damage, and chronic inflammation from multiple pathways simultaneously.

What is the half-life of GLOW (GHK-Cu + TB-500 + BPC-157)?

The half-life of GLOW (GHK-Cu + TB-500 + BPC-157) is Blend half-life varies by component (1-4 hours). Designed for once-daily injection as a pre-mixed formulation..

What dosage of GLOW (GHK-Cu + TB-500 + BPC-157) has been studied?

Described in research: 2.3 mg. May vary by formulation – dose based on total vial content and supplier guidelines. , frequency: Daily subcutaneous injection (per supplier protocol). This is not a medical recommendation.

How long is a GLOW (GHK-Cu + TB-500 + BPC-157) cycle?

Typical cycle length in studies: 8-12 weeks on, 4 weeks off.

What are the side effects of GLOW (GHK-Cu + TB-500 + BPC-157)?

Injection site redness/irritation · Mild headache (first few days) · Temporary flushing (GHK-Cu) · Mild fatigue during initial healing response · Nausea (BPC-157, usually with oral dosing) · Mild dizziness · Temporary increase in inflammation (healing response) · Allergic reaction to copper component · Blood pressure fluctuations · Combined angiogenic risk (Frequency: Theoretical): GLOW contains…

How well researched is GLOW (GHK-Cu + TB-500 + BPC-157)?

Limited research (2/5). Few, small or uncontrolled human data; mostly animal studies.

Comparisons